134 related articles for article (PubMed ID: 36148613)
1. A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells.
Li S; Li Z; Li Y; Zhu Y; Han J; Li W; Jin N; Fang J; Li X; Zhu G
J Cell Mol Med; 2022 Oct; 26(20):5222-5234. PubMed ID: 36148613
[TBL] [Abstract][Full Text] [Related]
2. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro.
Tian Y; Yao W; He D; Xu Y; Li Y; Zhu Y; Fang J; Bai B; Li X; Sun L; Jin N
Anticancer Drugs; 2020 Feb; 31(2):110-122. PubMed ID: 31658131
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells.
Cui Y; Li Y; Li S; Li W; Zhu Y; Wang J; Liu X; Yue Y; Jin N; Li X
Exp Cell Res; 2020 Nov; 396(1):112185. PubMed ID: 32828827
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo.
Wang J; Zuo S; Zhang Y; Li S; Shi Y; Du T; Han J; Jin N; Li Y; Li X
Cancer Manag Res; 2022; 14():2749-2761. PubMed ID: 36133740
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.
Li T; Fang J; Chu J; Liu X; Li Y; Zhu Y; Li S; Xiu Z; Li Y; Jin N; Zhu G; Sun L; Li X
J Cancer Res Clin Oncol; 2022 May; 148(5):1073-1085. PubMed ID: 35038020
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer.
Wang J; Li Y; Li S; Yao W; Liu X; Zhu Y; Li W; Sun L; Jin N; Li X
Front Oncol; 2020; 10():244. PubMed ID: 32269962
[TBL] [Abstract][Full Text] [Related]
7. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells.
Li W; Li Y; Cui Y; Li S; Zhu Y; Shang C; Song G; Liu Z; Xiu Z; Cong J; Li T; Li X; Sun L; Jin N
J Cell Mol Med; 2021 Jan; 25(2):666-676. PubMed ID: 33305893
[TBL] [Abstract][Full Text] [Related]
9. Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells.
Li Y; Zhu Y; Han J; Fang J; Xiu Z; Li S; Li W; Yang X; Jin N; Sun L; Li X; Li Y
Front Mol Biosci; 2021; 8():763500. PubMed ID: 34869595
[TBL] [Abstract][Full Text] [Related]
10. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo.
Li M; Zhu Y; Bai B; Fang J; Yao W; Li Y; Li S; Li X; Jin N; Jiang R
Cancer Biomark; 2021; 32(3):251-262. PubMed ID: 34459386
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells.
Cui CX; Li YQ; Sun YJ; Zhu YL; Fang JB; Bai B; Li WJ; Li SZ; Ma YZ; Li X; Wang WH; Jin NY
Urol Oncol; 2019 Jun; 37(6):352.e1-352.e18. PubMed ID: 30665692
[TBL] [Abstract][Full Text] [Related]
12. Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.
Zhang M; Wang J; Li C; Hu N; Wang K; Ji H; He D; Quan C; Li X; Jin N; Li Y
Int J Oncol; 2013 Mar; 42(3):1052-60. PubMed ID: 23338489
[TBL] [Abstract][Full Text] [Related]
13. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.
Li X; Liu Y; Wen Z; Li C; Lu H; Tian M; Jin K; Sun L; Gao P; Yang E; Xu X; Kan S; Wang Z; Wang Y; Jin N
Mol Cancer; 2010 Jan; 9():10. PubMed ID: 20085660
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
15. Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine.
Liu X; Yang Z; Li Y; Zhu Y; Li W; Li S; Wang J; Cui Y; Shang C; Liu Z; Song G; Li C; Li X; Shao G; Jin N
Front Oncol; 2020; 10():229. PubMed ID: 32158698
[TBL] [Abstract][Full Text] [Related]
16. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
17. Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo.
Song G; Shang C; Sun L; Li Y; Zhu Y; Xiu Z; Liu Z; Li Y; Yang X; Ge C; Fang J; Jin N; Li X
Invest New Drugs; 2022 Apr; 40(2):274-289. PubMed ID: 34981275
[TBL] [Abstract][Full Text] [Related]
18. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
19. Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models.
Shang C; Zhu YL; Li YQ; Song GJ; Ge CC; Lu J; Xiu ZR; Li WJ; Li SZ; Cong JN; Liu ZR; Li X; Sun LL; Jin NY
Invest New Drugs; 2021 Aug; 39(4):949-960. PubMed ID: 33534026
[TBL] [Abstract][Full Text] [Related]
20. The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells.
Fan J; Jiang H; Cheng L; Liu R
Oncol Rep; 2016 Mar; 35(3):1741-9. PubMed ID: 26718317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
